References
- Mayers C. N., Holley J. L., Brooks T. Antitoxin therapy for botulinum intoxication. Rev. Med. Micro. 2001; 12(1)29–37
- Bardenwarper H. W. Serum neuritis from tetanus antitoxin. JAMA 1962; 179: 763–766
- Black R. E., Gunn R. A. Hypersensitivity reactions associated with botulinal antitoxin. Am. J. Med. 1980; 69: 567–570
- Dillman R. O. Human antimouse and antiglobulin responses to monoclonal antibodies. Antibody Immunoconj. Radiopharm. 1990; 3: 1–15
- Blumenthal R. D., Sharkey R. M., Synder D., Goldenberg D. M. Reduction by anti‐antibody administration of the radiotoxicity associated with 131I‐labelled antibody to carcinoembryonic antigen in cancer radioimmunotherapy. J. Natl. Cancer Inst. 1989; 81(3)194–199
- Kashmiri S. V., Iwahashi M., Tamura M., Padlan E. A., Milenic D. E., Schlom J. Development of a minimally immunogenic variant of humanized anti‐carcinoma monoclonal antibody CC49. Crit. Rev. Oncol. Hematol. 2001; 38(1)3–16
- Kricka L. J. Human anti‐animal antibody interferences in immunological assays. Clin. Chem. 1999; 45(7)942–956
- Hibbs R. G., Weber J. T., Corwin A., Allos B. M., Abd el Rehim M. S., Sharkawy S. E., Sarn J. E., McKee J. T. Experience with the use of an investigational F(ab′)2 heptavalent botulism immune globulin of equine origin during an outbreak of type E botulism in Egypt. Clin. Infect. Dis. 1996; 23(2)337–340
- Smith T. W., Lloyd B. L., Spicer N., Haber E. Immunogenicity and kinetics of distribution and elimination of sheep digoxin‐specific IgG and Fab fragments in the rabbit and baboon. Clin. Exp. Immunol. 1979; 36: 384–396
- Kearns G. L., Moss M. M., Clayton B. D., Hewett D. D. Pharmacokinetics and efficacy of digoxin specific Fab fragments in a child following massive digoxin overdose. J. Clin. Pharmacol. 1989; 29: 901–908
- Smith T. W. Review of clinical experience with digoxin immune Fab (ovine). Am. J. Emer. Med. 1991; 9: 1–6
- Sjostrom L., Al‐Abdulla I. H., Rawat S., Smith D. C., Landon J. A comparison of ovine and equine antivenoms. Toxicon 1994; 32(4)427–433
- Kirkpatrick C. H. Allergic histories and reactions of patients treated with digoxin immune Fab (ovine) antibody. Am. J. Emerg. Med. 1991; 9: 7–10
- Hatheway C. H., Snyder J. D., Seals J. E., Edell T. A., Lewis G. E. Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E. J. Infect. Dis. 1984; 150(3)407–412